Ranked by engagement
Top topics — all time page 26
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 26 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Residual solvents and scavengers: what is looked for — what changed since
Residual solvents and scavengers: what is looked for — what changed since — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three…
|
+37 | 41 | 7k | 2mo |
|
Electrolyte supplements: which ones do anything — a second dataset
Electrolyte supplements: which ones do anything — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is the part of this…
|
2 | 59k | 15mo | |
|
Second pass at: Submitting a sample: the process end to end
Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better…
|
+12 | 16 | 41k | 4mo |
|
Enforcement priorities versus written rules
Enforcement priorities versus written rules — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal, separately from product quality.…
|
2 | 62k | 15mo | |
|
Ultrasound and skinfolds: operator dependence in practice — what changed since
Posting this under the heading it deserves: Ultrasound and skinfolds: operator dependence in practice — what changed since Everything below is what sits behind that. Longitudinal report with the method…
|
+32 | 37 | 7.4k | 3mo |
|
When a dose reduction is the correct response to a side effect — a second dataset
When a dose reduction is the correct response to a side effect — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on…
|
+10 | 14 | 42k | 2mo |
|
A side-effect grading scheme this community uses, and its limits — the long version
A side-effect grading scheme this community uses, and its limits — the long version — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in…
|
+19 | 23 | 29k | 20mo |
|
Bleeding at the injection site: normal, and what to do about it
Bleeding at the injection site: normal, and what to do about it — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the…
|
3 | 59k | 8mo | |
|
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. A logistics question, since the…
|
+50 | 56 | 780 | 8mo |
|
Pen wastage and its effect on real cost
Pen wastage and its effect on real cost Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines…
|
+29 | 33 | 19k | 21mo |
|
Sample size intuition for a personal experiment
On the subject in the title: Sample size intuition for a personal experiment Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting; the discussion is…
|
4 | 62k | 18mo | |
|
Why appetite effects are mostly central
Why appetite effects are mostly central I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first three replies will…
|
2 | 56k | 16mo | |
|
Immortal time bias in a claims-database study — one year on
Posting this under the heading it deserves: Immortal time bias in a claims-database study — one year on Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with SURMOUNT-1 (…
|
+41 | 46 | 3.7k | 22h |
|
History of disordered eating and why it changes the conversation
History of disordered eating and why it changes the conversation Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+20 | 24 | 30k | 8mo |
|
Revisiting: Filing a first vendor report: a worked example
On the subject in the title: Revisiting: Filing a first vendor report: a worked example Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers…
|
2 | 60k | 11mo | |
|
The most common factual error about semaglutide on the internet — what changed since
The most common factual error about semaglutide on the internet — what changed since — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with STEP 1 ( N…
|
+42 | 46 | 1.7k | 5mo |
|
Tracking a preprint to publication: a worked example — the long version
Posting this under the heading it deserves: Tracking a preprint to publication: a worked example — the long version Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with STEP 2 (…
|
+38 | 47 | 560 | 22mo |
|
Publication patterns in the BPC-157 literature, examined
Posting this under the heading it deserves: Publication patterns in the BPC-157 literature, examined Everything below is what sits behind that. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in support of…
|
+40 | 45 | 3.4k | 21h |
|
A vial that will not fully dissolve: what to check and in what order
A vial that will not fully dissolve: what to check and in what order — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how…
|
+12 | 16 | 40k | 15mo |
|
Second pass at: Designing a personal experiment that could change your mind
Second pass at: Designing a personal experiment that could change your mind Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please…
|
+39 | 44 | 632 | 14mo |
|
Mood changes: monitoring, and when to involve a professional — what changed since
Mood changes: monitoring, and when to involve a professional — what changed since Writing it up because I had to work it out twice and would rather nobody else did. General question, not a request for advice…
|
+6 | 10 | 45k | 25d |
|
Revisiting: Filter needles: when they help and what they cost you
Revisiting: Filter needles: when they help and what they cost you — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the…
|
+48 | 52 | 6.6k | 11mo |
|
[2026 update] US compounding rules and how they changed
US compounding rules and how they changed Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this category expires.…
|
+32 | 37 | 7.4k | 10mo |
|
Multiplicity when you track fifteen variables
Multiplicity when you track fifteen variables — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURMOUNT-OSA ( N Engl J Med , 2024) and finding…
|
2 | 60k | 11mo | |
|
About the Impurities & related substances category
Deletion sequences, oxidation, deamidation, aggregates, residual solvents, and counter-ion content. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
+6 | 10 | 50k | 15h |
|
What the GIP component of tirzepatide is thought to contribute, and how confident we can be — the long version
Asking directly, because I could not find a straight answer: What the GIP component of tirzepatide is thought to contribute, and how confident we can be — the long version Comparing PIONEER 6 ( N Engl J Med ,…
|
+48 | 52 | 609 | 10mo |
|
An orphaned page with no inbound links
An orphaned page with no inbound links — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps…
|
+44 | 48 | 7.5k | 14mo |
|
Guidelines revision: what changed and why — does this still hold?
Guidelines revision: what changed and why — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Process question about how this site works. I have…
|
2 | 58k | 7mo | |
|
How this community escalates rather than diagnoses
How this community escalates rather than diagnoses — that is the question, and I have not found it answered plainly anywhere I have looked. Asking about a population rather than about a person. The published…
|
4 | 51k | 8mo | |
|
When a red flag was a misunderstanding, and the retraction
When a red flag was a misunderstanding, and the retraction — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to talk about documentation quality as a…
|
+34 | 38 | 8.3k | 21mo |